Status:
COMPLETED
Diagnostic Value of 18F-Fluoride-PET/MRI in the Management of Suspected Facet Joint Arthropathy
Lead Sponsor:
Balgrist University Hospital
Collaborating Sponsors:
University of Zurich
Conditions:
Arthropathy of Lumbar Facet
Pain, Back
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Prior to the injection, the facet joints have to be defined according to standard radiological techniques (e.g. MRI and physical correlation). Patients are then sent to 18F-Fluoride-PET/MRI imaging, i...
Eligibility Criteria
Inclusion
- Patients over 18 years old with low back pain who have failed conservative management in the primary care setting, namely, analgesia and physical therapy.
- Imaging evidence (e.g. MRI) of facet joint degeneration, such as facet hypertrophy, subchondral sclerosis, and joint space narrowing.
- Obtained informed consent
Exclusion
- had undergone prior spinal surgery or prior facet joint injections or
- had other spinal abnormalities (benign or malignant tumors, congenital defects, isthmic spondylolisthesis) or
- are unable to tolerate PET/MRI imaging
- are pregnant or nursing.
Key Trial Info
Start Date :
May 26 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 24 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03317275
Start Date
May 26 2017
End Date
April 24 2020
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinic Balgrist
Zurich, Canton of Zurich, Switzerland, 8008